SCHEMBL94354

SCHEMBL94354

[CH2]C(N)CN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21222729 1.00
SCHEMBL23877972 1.00
SCHEMBL5176960 0.74
SCHEMBL10976879 0.73
SCHEMBL94871 0.70
SCHEMBL1509664 0.70
SCHEMBL6432174 0.70 ALDH1A1 (0.35)
SCHEMBL5400057 0.70
SCHEMBL16111087 0.70
SCHEMBL522260 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 166 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11186583-B2 5-alkylthio-7-[(4-arylbenzyl)amino]-1(2)H-pyrazolo[4,3-d]pyrimidines for treatment of lymphoma UNIVERZITA PALACKEHO V OLOMOUCI (CZ) 2021-11-30 US claimed
EP-3749670-B1 5-ALKYLTHIO-7-[(4-ARYLBENZYL)AMINO]-1(2)H-PYRAZOLO[4,3-D]PYRIMIDINES FOR TREATMENT OF LYMPHOMA UNIV PALACKEHO (CZ) 2021-10-06 EP claimed
EP-3749670-A1 5-ALKYLTHIO-7-[(4-ARYLBENZYL)AMINO]-1(2)H-PYRAZOLO[4,3-D]PYRIMIDINES FOR TREATMENT OF LYMPHOMA Univerzita Palackeho v Olomouci (CZ) 2020-12-16 EP claimed
US-20200361943-A1 5-ALKYLTHIO-7-[(4-ARYLBENZYL)AMINO]-1(2)H-PYRAZOLO[4,3-D]PYRIMIDINES FOR TREATMENT OF LYMPHOMA UNIVERZITA PALACKEHO V OLOMOUCI (CZ) 2020-11-19 US claimed
WO-2019149295-A1 5-ALKYLTHIO-7-[(4-ARYLBENZYL)AMINO]-1(2)H-PYRAZOLO[4,3-D]PYRIMIDINES FOR TREATMENT OF LYMPHOMA UNIVERZITA PALACKEHO V OLOMOUCI (CZ) 2019-08-08 WO claimed
EP-3096751-A1 12-EPI-PLEUROMUTILINS Nabriva Therapeutics AG (AT) 2016-11-30 EP claimed
WO-2015110481-A1 12-EPI-PLEUROMUTILINS NABRIVA THERAPEUTICS AG (AT) 2015-07-30 WO claimed
EP-2726521-A1 VINYL ALCOHOL POLYMERS WITH SILANE SIDE CHAINS Revolymer Limited (GB) 2014-05-07 EP claimed
WO-2013001313-A1 VINYL ALCOHOL POLYMERS WITH SILANE SIDE CHAINS REVOLYMER LIMITED (GB) 2013-01-03 WO claimed
US-20100137440-A1 LYSINE RIBOSWITCHES, STRUCTURE-BASED COMPOUND DESIGN WITH LYSINE RIBOSWITCHES, AND METHODS AND COMPOSITIONS FOR USE OF AND WITH LYSINE RIBOSWITCHES YALE UNIVERSITY (US) 2010-06-03 US claimed
EP-2061799-A2 METHODS AND COMPOSITIONS FOR THE USE OF LYSINE RIBOSWITCHES YALE UNIVERSITY (US) 2009-05-27 EP claimed
WO-2008033866-A2 METHODS AND COMPOSITIONS FOR THE USE OF LYSINE RIBOSWITCHES YALE UNIVERSITY (US) 2008-03-20 WO claimed
US-7060110-B2 Dyeing composition for dyeing keratinous fibres comprising a particular dicationic monoazo dye L'OREAL (FR) 2006-06-13 US claimed
US-20040093676-A1 Novel dyeing composition for dyeing keratinous fibres comprising a particular dicationic monoazo dye L'OREAL S.A. (FR) 2004-05-20 US claimed
US-5981521-A USEFUL FOR TREATING VARIOUS HORMONE DEPENDENT DISEASES, INCLUDING PROSTATE CANCER, ENDOMETRIOSIS, UTERINE FIBROIDS, PRECOCIOUS PUBERTY, BENIGN PROSTATE HYPERTROPY AND IN VITRO FERTILIZATION ABBOTT LABORATORIES (US) 1999-11-09 US claimed
EP-0576445-A1 A COMPOSITION FOR USE IN WASHING AND CLEANSING VULCANIZATION MOLDS. SILVANI ANTINCENDI SPA (IT) 1994-01-05 EP claimed
CN-118344363-A Tricyclic fused ring derivatives and uses thereof 广东东阳光药业股份有限公司 2024-07-16 CN disclosed
CN-113227079-B Compound as IRAK inhibitor 上海美悦生物科技发展有限公司 2024-06-04 CN disclosed
EP-0055099-A1 Penicillin derivatives ICI PHARMA (FR) 1982-06-30 EP disclosed
EP-0025199-A2 Cephem compounds, processes for their preparation and pharmaceutical compositions containing them FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1981-03-18 EP disclosed